Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.27
+0.61 (9.16%)
At close: Jun 9, 2026, 4:00 PM EDT
7.26
-0.01 (-0.14%)
After-hours: Jun 9, 2026, 7:42 PM EDT

Unicycive Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
37.3729.226.149.70.4616.58
Short-Term Investments
17.2212.07----
Cash & Short-Term Investments
54.5941.2726.149.70.4616.58
Cash Growth
176.12%57.87%169.48%2032.09%-97.26%-
Other Current Assets
8.967.694.813.72.191.83
Total Current Assets
63.5548.9630.9513.42.6418.41
Net Property, Plant & Equipment
0.860.170.720.790.170.33
Total Assets
64.4149.1431.6714.192.8218.74
Accounts Payable
1.140.381.060.840.890.74
Accrued Expenses
3.051.523.563.232.241.21
Current Portion of Leases
0.60.120.560.330.160.15
Other Current Liabilities
21.716.9218.9413.13--
Total Current Liabilities
26.4918.9424.1217.533.282.11
Long-Term Leases
0.22-0.120.47-0.16
Total Long-Term Liabilities
0.22-0.120.47-0.16
Total Liabilities
26.718.9424.24183.282.26
Common Stock
0.030.020.010.040.020.02
Additional Paid-in Capital
178.32158108.6960.733.5232.41
Accumulated Other Comprehensive Income
0.01-0----
Retained Earnings
-140.65-127.83-101.27-64.54-34-15.94
Shareholders' Equity
37.730.27.43-3.81-0.4716.48
Total Liabilities & Equity
64.4149.1431.6714.192.8218.74
Total Debt
0.820.120.680.790.160.31
Net Cash (Debt)
53.7741.1525.468.910.316.27
Net Cash Growth
30.66%61.63%185.82%2869.33%-98.16%-
Net Cash Per Share
0.012.593.803.630.2013.94
Book Value
37.730.27.43-3.81-0.4716.48
Book Value Per Share
0.011.901.11-1.55-0.3114.12
Tangible Book Value
37.730.27.43-3.81-0.4716.48
Tangible Book Value Per Share
0.011.901.11-1.55-0.3114.12
SEC Filings: 10-K · 10-Q